J Korean Surg Soc.
1998 Dec;55(Suppl):985-990.
Clinical Significance of Cellular Fibronectin as a Tumor Marker
in Gastric Cancer Patients
- Affiliations
-
- 1Departments of Surgery and 1Clinical Pathology, College of Medicine, Catholic University of Taegu-Hyosung.
Abstract
- BACKGROUND
: Fibronectins (FNs) are adhesive glycoproteins that have variable primary structures owing to cell type-specific splicing of the FN precursor mRNA. FNs can be classified as plasma (p-FN) and cellular (c-FN) types, and c-FN may play a role as a marker of malignancies. CEA and CA 125 have been reported as useful tumor markers, but FNs have not studied adequately in gastric cancers.
METHODS
: We evaluated the clinical significance of urinary and plasma c-FN in thirty-five patients
who were operated on our department due to gastric cancer from January 1997 to August 1997. The
c-FN level was determined by enzyme immunoassay using a FIBRONECTIN EIA kit (Takara Shuzo
Co., Kyoto, Japan).
RESULTS
: The levels of urine c-FN in gastric cancer patients (215.6 470.2) were higher than those
in the control groups (94.1 63.0 ng/mgCr) and also showed a tendency to increase with advancing of
tumor growth. A higher rate of increased urine c-FN also was identified in patients with distant metastasis
than in patients without distant metastasis (6/8 vs. 10/27, p=0.05). However, p-FN didn't showed any
differences according to extent of tumor invasion and/or presence of distant metastasis. Other parameters,
such as age, sex, preoperative tumor size, and depth of invasion, were not correlated with urine and
plasma c-FN.
CONCLUSIONS
: Urine c-FN may be useful as a new tumor marker in gastric cancer and can be helpful
in early detection of metastasis and peritoneal seeding, but further studies and follow up are needed
for complete clinical application.